Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma.
Tateishi K, Miyake Y, Nakamura T, Iwashita H, Hayashi T, Oshima A, Honma H, Hayashi H, Sugino K, Kato M, Satomi K, Fujii S, Komori T, Yamamoto T, Cahill DP, Wakimoto H. Tateishi K, et al. Among authors: komori t. Acta Neuropathol Commun. 2023 Nov 27;11(1):186. doi: 10.1186/s40478-023-01683-x. Acta Neuropathol Commun. 2023. PMID: 38012788 Free PMC article.
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
Neyazi S, Yamazawa E, Hack K, Tanaka S, Nagae G, Kresbach C, Umeda T, Eckhardt A, Tatsuno K, Pohl L, Hana T, Bockmayr M, Kim P, Dorostkar MM, Takami T, Obrecht D, Takai K, Suwala AK, Komori T, Godbole S, Wefers AK, Otani R, Neumann JE, Higuchi F, Schweizer L, Nakanishi Y, Monoranu CM, Takami H, Engertsberger L, Yamada K, Ruf V, Nomura M, Mohme T, Mukasa A, Herms J, Takayanagi S, Mynarek M, Matsuura R, Lamszus K, Ishii K, Kluwe L, Imai H, von Deimling A, Koike T, Benesch M, Kushihara Y, Snuderl M, Nambu S, Frank S, Omura T, Hagel C, Kugasawa K, Mautner VF, Ichimura K, Rutkowski S, Aburatani H, Saito N, Schüller U. Neyazi S, et al. Among authors: komori t. Acta Neuropathol. 2024 Jan 24;147(1):22. doi: 10.1007/s00401-023-02668-9. Acta Neuropathol. 2024. PMID: 38265489 Free PMC article.
DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma.
Harachi M, Masui K, Shimizu E, Murakami K, Onizuka H, Muragaki Y, Kawamata T, Nakayama H, Miyata M, Komori T, Cavenee WK, Mischel PS, Kurata A, Shibata N. Harachi M, et al. Among authors: komori t. Acta Neuropathol Commun. 2024 Mar 13;12(1):40. doi: 10.1186/s40478-024-01750-x. Acta Neuropathol Commun. 2024. PMID: 38481314 Free PMC article.
MYB::QKI fusion-positive diffuse glioma of the cerebellum: A case report.
Satomi K, Shibayama T, Hibiya T, Hayashi A, Nagahama K, Kato K, Nikai Y, Matsushita Y, Gomyo M, Yamagishi Y, Sasaki N, Saito K, Kobayashi K, Takeda A, Fujimoto S, Matsuo T, Takai K, Komori T, Tsuchiya K, Nagane M, Ichimura K, Shibahara J. Satomi K, et al. Among authors: komori t. Neuropathology. 2024 Nov 21. doi: 10.1111/neup.13016. Online ahead of print. Neuropathology. 2024. PMID: 39569742
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups.
Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, Kim MM, Huse JT, Schnell O, Harter PN, Mohme M; Expert Rater Panel; von Baumgarten L, Albert NL, Huang RY, Mehta MP, van den Bent M, Weller M, Vogelbaum MA, Chang SM, Berger MS, Tonn JC. Karschnia P, et al. Lancet Oncol. 2023 Nov;24(11):e438-e450. doi: 10.1016/S1470-2045(23)00453-9. Lancet Oncol. 2023. PMID: 37922934 Free PMC article. Review.
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma.
Masui K, Onizuka H, Muragaki Y, Kawamata T, Kurata A, Komori T. Masui K, et al. Among authors: komori t. Brain Tumor Pathol. 2024 Apr;41(2):92-95. doi: 10.1007/s10014-024-00484-x. Epub 2024 Apr 10. Brain Tumor Pathol. 2024. PMID: 38597998 No abstract available.
A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomas.
Muragaki Y, Ishikawa E, Maruyama T, Nitta M, Saito T, Ikuta S, Komori T, Kawamata T, Yamamoto T, Tsuboi K, Matsumura A, Nakamura H, Kuroda J, Abe T, Momii Y, Saito R, Tominaga T, Tabei Y, Suzuki I, Arakawa Y, Miyamoto S, Matsutani M, Karasawa K, Nakazato Y, Maebayashi K, Hashimoto K, Ohno T. Muragaki Y, et al. Among authors: komori t. J Neurosurg. 2023 Jan 20;139(2):344-354. doi: 10.3171/2022.12.JNS221221. Print 2023 Aug 1. J Neurosurg. 2023. PMID: 36670529 Clinical Trial.
1,357 results